Lakeland Regional Health Hollis Cancer Center — Lakeland, Florida

Lakeland Regional Health Hollis Cancer Center is a clinical research site located in Lakeland, Florida, United States 33805.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Lakeland Regional Health Hollis Cancer Center has participated in 40 clinical trials with 20 currently active.

Therapeutic areas: mCRPC, Myelodysplastic Syndromes (MDS), Upper Tract Urothelial Carcinomas.

Sponsors: Pfizer, National Heart, Lung, and Blood Institute (NHLBI), QED Therapeutics, a BridgeBio company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lakeland

Browse all research sites in Florida · View every site in Lakeland

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lakeland Regional Health Hollis Cancer Center?

Lakeland Regional Health Hollis Cancer Center has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lakeland Regional Health Hollis Cancer Center conducted?

Lakeland Regional Health Hollis Cancer Center has 40 clinical trials on record, with 20 currently active. Their work covers mCRPC, Myelodysplastic Syndromes (MDS), Upper Tract Urothelial Carcinomas.

Is Lakeland Regional Health Hollis Cancer Center accredited by Crixeo Clinical Trials?

Lakeland Regional Health Hollis Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lakeland Regional Health Hollis Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.